Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005
- PMID: 20019308
- PMCID: PMC2920986
- DOI: 10.2105/AJPH.2009.160184
Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005
Abstract
Objectives: To determine the effects of program policy changes, we examined service delivery benchmarks for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Methods: We analyzed NBCCEDP data for women with abnormal mammogram or clinical breast examination (n=382 416) from which 23 701 cancers were diagnosed. We examined time to diagnosis and treatment for 2 time periods: 1996 to 2000 and 2001 to 2005. We compared median time for diagnostic, treatment initiation, and total intervals with the Kruskal-Wallis test. We calculated adjusted proportions (predicted marginals) with logistic regression to examine diagnosis and treatment within program benchmarks (<or=60 days) and time from screening to treatment (<or=120 days).
Results: Median diagnostic intervals decreased by 2 days (25 vs 23; P<.001). Median treatment initiation intervals increased by 2 days (12 vs 14; P<.001). Total intervals decreased by 3 days (43 vs 40; P<.001). Women meeting the 60-day benchmark for diagnosis improved the most for women with normal mammograms and abnormal clinical breast examinations from 77% to 82%.
Conclusions: Women screened by the NBCCEDP received diagnostic follow-up and initiated treatment within preestablished program guidelines.
Figures

Similar articles
-
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.J Womens Health (Larchmt). 2012 Jul;21(7):776-82. doi: 10.1089/jwh.2011.3224. Epub 2012 Apr 16. J Womens Health (Larchmt). 2012. PMID: 22506920 Free PMC article.
-
Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.Cancer Causes Control. 2015 May;26(5):723-32. doi: 10.1007/s10552-015-0567-7. Epub 2015 Mar 26. Cancer Causes Control. 2015. PMID: 25809209 Free PMC article.
-
Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995.Am J Public Health. 2000 Jan;90(1):130-4. doi: 10.2105/ajph.90.1.130. Am J Public Health. 2000. PMID: 10630153 Free PMC article.
-
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55. MMWR Recomm Rep. 2000. PMID: 15580731
-
Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States).Cancer Causes Control. 2006 Feb;17(1):29-38. doi: 10.1007/s10552-005-4558-y. Cancer Causes Control. 2006. PMID: 16411050
Cited by
-
Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan.Sci Rep. 2022 Nov 7;12(1):18915. doi: 10.1038/s41598-022-23683-y. Sci Rep. 2022. PMID: 36344740 Free PMC article.
-
Evaluation of waiting times for breast cancer diagnosis and surgical treatment.Clin Transl Oncol. 2018 Oct;20(10):1345-1352. doi: 10.1007/s12094-018-1867-7. Epub 2018 Apr 9. Clin Transl Oncol. 2018. PMID: 29633184
-
Multilevel contributors to racial and ethnic inequities in the resolution of abnormal mammography results.Cancer Causes Control. 2024 Jul;35(7):995-1009. doi: 10.1007/s10552-024-01851-x. Epub 2024 Mar 13. Cancer Causes Control. 2024. PMID: 38478206 Free PMC article.
-
Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.Cancer Causes Control. 2025 May 6:10.1007/s10552-025-02006-2. doi: 10.1007/s10552-025-02006-2. Online ahead of print. Cancer Causes Control. 2025. PMID: 40327212 Free PMC article.
-
Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data.J Cancer Surviv. 2023 Aug;17(4):917-950. doi: 10.1007/s11764-022-01282-0. Epub 2022 Nov 12. J Cancer Surviv. 2023. PMID: 36369622
References
-
- Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792 - PubMed
-
- Olivotto IA, Gomi A, Bancej C, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer. 2002;94(8):2143–2150 - PubMed
-
- Ganry O, Peng J, Dubreuil A. Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen. 2004;11(1):28–31 - PubMed
-
- Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–1126 - PubMed
-
- Yabroff KR, Washington KS, Leader A, et al. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003;60(3):294–331 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical